3416400778

BIBLIOGRAPHIE

Liang, S.H. and Ciarkę, M.F. A bipartite nuclear localization signal is reąuired for p53 nuclear import regulated by a carboxyl-terminal domain. J Biol Chem 1999; 274: 32699-32703.

Lin, Y., Ma, W. and Benchimol, S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet 2000; 26: 122-127.

Lin, Y.Z., Yao, S.Y., Veach, R.A., Torgerson, T.R. and Hawiger, J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide eon tai ni ng a celi membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270: 14255-14258.

Linzer, D.I. and Levine, A.J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Celi 1979; 17: 43-52.

Liu, Q., Guntuku, S., Cui, X.S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., Donehower, L.A. and Eiledge, S.J. Chkl is an essential kinase that is regulated by Atr and recjuired for the G(2)/M DNA damage checkpoint. Genes Dev 2000a; 14: 1448-1459.

Liu, X., Kim, C.N., Yang, J., Jemmerson, R. and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Celi 1996; 86: 147-157.

Liu, Y., McKalip, A. and Herman, B. Humań papiIlomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. J Celi Biochem 2000b; 78: 334-349.

Lohrum, M.A., Woods, D.B., Ludwig, R.L., Balint, E. and Vousden, K.H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol Celi Biol 2001; 21: 8521-8532.

Lonn, U. and Lonn, S. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma. Cancer Res 1984; 44: 3414-3418.

Lowry, O.H., Rosehrough, N.J., Farr, A.R. and Randall, R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265-275.

Lu, H. and Levine, A.J. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc Natl Acad Sci USA 1995; 92: 5154-5158.

Lu, J.Z., Sun, Y.N., Rosę, R.C., Bonnez, W. and McCance, D.J. Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papilIomavinis type 11 origin. J Virol 1993; 67: 7131-7139.

Maity, A., McKenna, W.G. and Muschel, R.J. The molecular basis for celi cycle delays following ionizing radiation: a review. Radiother Oncol 1994; 31: 1-13.

Maki, C.G., Huibregtsc, J.M. and Howley, P.M. In vivo ubiquitination and proteasome-mediated degradation of p53(l). Cancer Res 1996; 56: 2649-2654.

Mariotta, M., Perewusnyk, G., Koechli, O.R., Little, J.B., von Knebel Doeberitz, M., Mirimanoff, R.O. and Rutz, H.P. Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells. Strahlenther Onkol 1999; 175: 392-396.

Massimi, P. and Banks, L. Repression of p53 transcriptional activity by the HPV E7 proteins. Virology 1997; 227: 255-259.

Massimi, P., Pim, 1)., Bertoli, C., Bouvard, V. and Banks, L. Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 1999; 18: 7748-7754.

Matlashewski, G., Banks, L., Pini, D. and Crawford, L. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur J Biochem 1986; 154: 665-672.

177